ロード中...
Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
INTRODUCTION: Similar outcomes have been observed between patients with rheumatoid arthritis (RA) responding to tocilizumab (TCZ) with methotrexate (MTX) who discontinued vs. continued MTX and between patients receiving MTX who added TCZ vs. switched to TCZ monotherapy. This study examined MTX disco...
保存先:
| 出版年: | Rheumatol Ther |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7211217/ https://ncbi.nlm.nih.gov/pubmed/32232740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-020-00200-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|